Zealand Pharma A/S ZEAL.CO Stock
Zealand Pharma A/S Price Chart
Zealand Pharma A/S ZEAL.CO Financial and Trading Overview
| Zealand Pharma A/S stock price | 589.5 DKK |
| Previous Close | 276 DKK |
| Open | 276 DKK |
| Bid | 275.8 DKK x 0 |
| Ask | 276.2 DKK x 0 |
| Day's Range | 275.4 - 279.6 DKK |
| 52 Week Range | 82.6 - 286.6 DKK |
| Volume | 146.85K DKK |
| Avg. Volume | 283.06K DKK |
| Market Cap | 16.32B DKK |
| Beta (5Y Monthly) | 0.870881 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -12.44 DKK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 292.29 DKK |
ZEAL.CO Valuation Measures
| Enterprise Value | 13.8B DKK |
| Trailing P/E | N/A |
| Forward P/E | 388.7324 |
| PEG Ratio (5 yr expected) | 0.93 |
| Price/Sales (ttm) | 153.05492 |
| Price/Book (mrq) | 21.22424 |
| Enterprise Value/Revenue | 129.39 |
| Enterprise Value/EBITDA | -20.689 |
Trading Information
Zealand Pharma A/S Stock Price History
| Beta (5Y Monthly) | 0.870881 |
| 52-Week Change | 203.46% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 286.6 DKK |
| 52 Week Low | 82.6 DKK |
| 50-Day Moving Average | 240.48 DKK |
| 200-Day Moving Average | 203.44 DKK |
ZEAL.CO Share Statistics
| Avg. Volume (3 month) | 283.06K DKK |
| Avg. Daily Volume (10-Days) | 217.96K DKK |
| Shares Outstanding | 58.38M |
| Float | 39.63M |
| Short Ratio | N/A |
| % Held by Insiders | 0.18% |
| % Held by Institutions | 50.88% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -725.15% |
| Gross Margin | 119.08% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -30.42% |
| Return on Equity (ttm) | -153.90% |
Income Statement
| Revenue (ttm) | 106.66M DKK |
| Revenue Per Share (ttm) | 2.21 DKK |
| Quarterly Revenue Growth (yoy) | 24.39% |
| Gross Profit (ttm) | 103.99M DKK |
| EBITDA | -667036032 DKK |
| Net Income Avi to Common (ttm) | -1064203008 DKK |
| Diluted EPS (ttm) | -22.87 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1B DKK |
| Total Cash Per Share (mrq) | 19.34 DKK |
| Total Debt (mrq) | 512.55M DKK |
| Total Debt/Equity (mrq) | 76.13 DKK |
| Current Ratio (mrq) | 7.527 |
| Book Value Per Share (mrq) | 13.004 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -821875008 DKK |
| Levered Free Cash Flow (ttm) | -216960256 DKK |
Profile of Zealand Pharma A/S
| Country | Denmark |
| State | N/A |
| City | Copenhagen |
| Address | Sydmarken 11 |
| ZIP | 2860 |
| Phone | 45 88 77 36 00 |
| Website | https://www.zealandpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 220 |
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing both insulin and dasiglucagon. The company's pipeline includes Dasiglucagon that is in Phase III clinical trials for congenital hyperinsulinism. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. Zealand Pharma A/S has collaboration agreements with Sanofi-Aventis Deutschland GmbH; Boehringer Ingelheim International GmbH; Alexion Pharmaceuticals, Inc.; and Beta Bionics, Inc. The company was incorporated in 1998 and is headquartered in Copenhagen, Denmark.
Q&A For Zealand Pharma A/S Stock
What is a current ZEAL.CO stock price?
Zealand Pharma A/S ZEAL.CO stock price today per share is 589.5 DKK.
How to purchase Zealand Pharma A/S stock?
You can buy ZEAL.CO shares on the Copenhagen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Zealand Pharma A/S?
The stock symbol or ticker of Zealand Pharma A/S is ZEAL.CO.
Which industry does the Zealand Pharma A/S company belong to?
The Zealand Pharma A/S industry is Biotechnology.
How many shares does Zealand Pharma A/S have in circulation?
The max supply of Zealand Pharma A/S shares is 62.27M.
What is Zealand Pharma A/S Price to Earnings Ratio (PE Ratio)?
Zealand Pharma A/S PE Ratio is now.
What was Zealand Pharma A/S earnings per share over the trailing 12 months (TTM)?
Zealand Pharma A/S EPS is -12.44 DKK over the trailing 12 months.
Which sector does the Zealand Pharma A/S company belong to?
The Zealand Pharma A/S sector is Healthcare.
Zealand Pharma A/S ZEAL.CO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| OMX_Nordic_Large_Cap_ISK_GI OMXNLCISKGI | 613.85 ISK 4.51 USD |
-0.11
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Large_Cap_DKK_GI OMXNLCDKKGI | 424.43 DKK 62.23 USD |
-0.09
|
— — | — — | — — | — - | — — |
| OMX Copenhagen Ex OMXC20 Index OMXCXC20GI | 15026.17 DKK 2203.15 USD |
-0.79
|
— — | — — | — — | — - | — — |
| OMX_Copenhagen_Large_Cap_PI OMXCLCPI | 561.78 DKK 82.37 USD |
+0.4
|
— — | — — | — — | — - | — — |
| OMX Copenhagen Cap_PI OMXCCAPPI | 1455.94 DKK 213.47 USD |
-0.6
|
— — | — — | — — | — - | — — |
| NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
| OMX Copenhagen Pharmaceuticals CX201030PI | 10605.7 DKK 1555.02 USD |
+1.02
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Large_Cap_SEK_GI OMXNLCSEKGI | 529.96 SEK 51.73 USD |
+0.39
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Large_Cap_EUR_GI OMXNLCEURGI | 424.25 EUR 463.76 USD |
-0.11
|
— — | — — | — — | — - | — — |
| OMX Copenhagen Ex OMXC20 Index OMXCXC20PI | 8216.95 DKK 1204.78 USD |
-0.79
|
— — | — — | — — | — - | — — |
| OMX Copenhagen_PI OMXCPI | 1847.14 DKK 270.83 USD |
+0.38
|
— — | — — | — — | — - | — — |
| OMX Copenhagen_GI OMXCGI | 3465.57 DKK 508.13 USD |
+0.39
|
— — | — — | — — | — - | — — |
| OMX Copenhagen Cap_GI OMXCCAPGI | 2771.14 DKK 406.31 USD |
-0.58
|
— — | — — | — — | — - | — — |
| OMX Copenhagen Health Care PI CX20PI | 9589.29 DKK 1405.99 USD |
+0.61
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}